The SPIRIT II Study - A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary.
Bioabsorbable Drug-Eluting Cardiac Stent Analysis
James Hermiller, MD, FACC, FSCAI The St Vincent Medical Group The St Vincent Heart Center of Indiana Indianapolis, IN Drug-Eluting Stents 2013: Current.
Bioabsorbable stents: early clinical results Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals.
New Drug-Eluting Stents Soo-Joong Kim M.D., PhD. Department of Cardiology, Internal Medicine, Kyung Hee University Medical Center.
CYPHER ® Clinical Evidence in Acute Myocardial Infarction (AMI)
Prison II
